Literature DB >> 15216933

Computational chemogenomics approaches to systematic knowledge-based drug discovery.

Jordi Mestres1.   

Abstract

Chemogenomics, the identification of all possible drugs for all possible targets, has recently emerged as a new paradigm in drug discovery in which efficiency in the compound design and optimization process is achieved through the gain and reuse of targeted knowledge. As targeted knowledge resides at the interface between chemistry and biology, computational tools aimed at integrating the chemical and biological spaces play a central role in chemogenomics. This review covers the recent progress made in integrative computational approaches to data annotation and knowledge generation for the systematic knowledge-based design and screening of chemical libraries.

Mesh:

Substances:

Year:  2004        PMID: 15216933

Source DB:  PubMed          Journal:  Curr Opin Drug Discov Devel        ISSN: 1367-6733


  14 in total

Review 1.  In silico pharmacology for drug discovery: methods for virtual ligand screening and profiling.

Authors:  S Ekins; J Mestres; B Testa
Journal:  Br J Pharmacol       Date:  2007-06-04       Impact factor: 8.739

Review 2.  Structure-based systems biology for analyzing off-target binding.

Authors:  Lei Xie; Li Xie; Philip E Bourne
Journal:  Curr Opin Struct Biol       Date:  2011-02-01       Impact factor: 6.809

Review 3.  Machine learning for in silico virtual screening and chemical genomics: new strategies.

Authors:  Jean-Philippe Vert; Laurent Jacob
Journal:  Comb Chem High Throughput Screen       Date:  2008-09       Impact factor: 1.339

4.  PharmMapper server: a web server for potential drug target identification using pharmacophore mapping approach.

Authors:  Xiaofeng Liu; Sisheng Ouyang; Biao Yu; Yabo Liu; Kai Huang; Jiayu Gong; Siyuan Zheng; Zhihua Li; Honglin Li; Hualiang Jiang
Journal:  Nucleic Acids Res       Date:  2010-04-29       Impact factor: 16.971

5.  The Mycobacterium tuberculosis drugome and its polypharmacological implications.

Authors:  Sarah L Kinnings; Li Xie; Kingston H Fung; Richard M Jackson; Lei Xie; Philip E Bourne
Journal:  PLoS Comput Biol       Date:  2010-11-04       Impact factor: 4.475

Review 6.  Rapid analysis of pharmacology for infectious diseases.

Authors:  Andrew L Hopkins; G Richard Bickerton; Ian M Carruthers; Stephen K Boyer; Harvey Rubin; John P Overington
Journal:  Curr Top Med Chem       Date:  2011       Impact factor: 3.295

7.  TransCent: computational enzyme design by transferring active sites and considering constraints relevant for catalysis.

Authors:  André Fischer; Nils Enkler; Gerd Neudert; Marco Bocola; Reinhard Sterner; Rainer Merkl
Journal:  BMC Bioinformatics       Date:  2009-02-10       Impact factor: 3.169

8.  C²Maps: a network pharmacology database with comprehensive disease-gene-drug connectivity relationships.

Authors:  Hui Huang; Xiaogang Wu; Ragini Pandey; Jiao Li; Guoling Zhao; Sara Ibrahim; Jake Y Chen
Journal:  BMC Genomics       Date:  2012-10-26       Impact factor: 3.969

9.  Insights into an original pocket-ligand pair classification: a promising tool for ligand profile prediction.

Authors:  Stéphanie Pérot; Leslie Regad; Christelle Reynès; Olivier Spérandio; Maria A Miteva; Bruno O Villoutreix; Anne-Claude Camproux
Journal:  PLoS One       Date:  2013-06-20       Impact factor: 3.240

10.  Genome-scale screening of drug-target associations relevant to Ki using a chemogenomics approach.

Authors:  Dong-Sheng Cao; Yi-Zeng Liang; Zhe Deng; Qian-Nan Hu; Min He; Qing-Song Xu; Guang-Hua Zhou; Liu-Xia Zhang; Zi-xin Deng; Shao Liu
Journal:  PLoS One       Date:  2013-04-05       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.